Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-05-27 @ 9:06 AM
Study NCT ID:
NCT00237458
Status:
COMPLETED
Last Update Posted:
2017-08-28
First Post:
2005-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain
Sponsor:
UCB Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP0647
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None